Skip to main content

LCD L34865: Magnetic Resonance Angiography (MRA)

LCD L34865, Magnetic Resonance Angiography (MRA), is the Local Coverage Determination that Novitas Solutions, Inc. applies to claims from 11 states plus DC (AR, CO, DC, DE, LA, MD, MS, NJ and others), effective 2020-07-01 and first in force 2015-10-01. The policy text runs 684 words, and its billing and coding article A56805 lists 999 ICD-10-CM codes that support medical necessity for 22 procedure codes. 3 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 999 covered ICD-10-CM codes: 194 fewer codes than L33633 (Wellpoint Federal, 1,193 codes, revised 2026-04-01) and 312 fewer codes than L34424 (Palmetto GBA, 1,311 codes, revised 2025-03-27).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Novitas Solutions, Inc.
States and territories
12
AR CO DC DE LA MD MS NJ NM OK PA TX
Revision effective
2020-07-01
Original effective
2015-10-01
Policy text
684 words
Covered ICD-10 codes (articles)
999

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34865
ContractContractorTypeStates
12101Novitas Solutions, Inc.A and B MACDE
12201Novitas Solutions, Inc.A and B MACDC
12301Novitas Solutions, Inc.A and B MACMD
12401Novitas Solutions, Inc.A and B MACNJ
12501Novitas Solutions, Inc.A and B MACPA
12102Novitas Solutions, Inc.A and B MACDE
12202Novitas Solutions, Inc.A and B MACDC
12302Novitas Solutions, Inc.A and B MACMD
12402Novitas Solutions, Inc.A and B MACNJ
12502Novitas Solutions, Inc.A and B MACPA
12901Novitas Solutions, Inc.A and B MACDC DE MD NJ PA
07102Novitas Solutions, Inc.A and B MACAR
07202Novitas Solutions, Inc.A and B MACLA
07101Novitas Solutions, Inc.A and B MACAR
07201Novitas Solutions, Inc.A and B MACLA
07301Novitas Solutions, Inc.A and B MACMS
07302Novitas Solutions, Inc.A and B MACMS
04111Novitas Solutions, Inc.A and B MACCO
04211Novitas Solutions, Inc.A and B MACNM
04311Novitas Solutions, Inc.A and B MACOK
04411Novitas Solutions, Inc.A and B MACTX
04112Novitas Solutions, Inc.A and B MACCO
04212Novitas Solutions, Inc.A and B MACNM
04312Novitas Solutions, Inc.A and B MACOK
04412Novitas Solutions, Inc.A and B MACTX
04911Novitas Solutions, Inc.A and B MACCO NM OK TX

Billing and coding article A56805: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56805 (Billing and Coding: Magnetic Resonance Angiography (MRA)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56805: Billing and Coding: Magnetic Resonance Angiography (MRA) (Billing and Coding, effective 2025-10-01)

Covered ICD-10-CM codes
999
4 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
22
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56805
ICD-10-CMDescription (FY2027)
A52.01Syphilitic aneurysm of aorta
A52.05Other cerebrovascular syphilis
A52.19Other symptomatic neurosyphilis
C00.0Malignant neoplasm of external upper lip
C00.1Malignant neoplasm of external lower lip
C00.2Malignant neoplasm of external lip, unspecified
C00.3Malignant neoplasm of upper lip, inner aspect
C00.4Malignant neoplasm of lower lip, inner aspect
C00.5Malignant neoplasm of lip, unspecified, inner aspect
C00.6Malignant neoplasm of commissure of lip, unspecified
C00.8Malignant neoplasm of overlapping sites of lip
C01Malignant neoplasm of base of tongue
C02.0Malignant neoplasm of dorsal surface of tongue
C02.1Malignant neoplasm of border of tongue
C02.2Malignant neoplasm of ventral surface of tongue
C02.3Malignant neoplasm of anterior two-thirds of tongue, part unspecified
C02.4Malignant neoplasm of lingual tonsil
C02.8Malignant neoplasm of overlapping sites of tongue
C02.9Malignant neoplasm of tongue, unspecified
C03.0Malignant neoplasm of upper gum
C03.1Malignant neoplasm of lower gum
C03.9Malignant neoplasm of gum, unspecified
C04.0Malignant neoplasm of anterior floor of mouth
C04.1Malignant neoplasm of lateral floor of mouth

Procedure codes: 70544, 70545, 70546, 70547, 70548, 70549, 71555, 72198, 73725, 74185, C8900 (Magnetic resonance angiography with contrast, abdomen), C8901 (Magnetic resonance angiography without contrast, abdomen), C8902 (Magnetic resonance angiography without contrast followed by with contrast, abdomen), C8909 (Magnetic resonance angiography with contrast, chest (excluding myocardium)), C8910 (Magnetic resonance angiography without contrast, chest (excluding myocardium)), C8911 (Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)), C8912 (Magnetic resonance angiography with contrast, lower extremity), C8913 (Magnetic resonance angiography without contrast, lower extremity), C8914 (Magnetic resonance angiography without contrast followed by with contrast, lower extremity), C8918 (Magnetic resonance angiography with contrast, pelvis), C8919 (Magnetic resonance angiography without contrast, pelvis), C8920 (Magnetic resonance angiography without contrast followed by with contrast, pelvis).

Coverage indications, limitations and medical necessity

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Magnetic resonance angiography (MRA) is a non-invasive diagnostic test that is an application of magnetic resonance imaging (MRI). By analyzing the amount of energy released from tissues exposed to a strong magnetic field, MRA provides images of normal and diseased blood vessels as well as visualization and quantification of blood flow through these vessels.

Please refer to the National Coverage Determination for MRI and MRA documented in CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, Section 220.2 Magnetic Resonance Imaging (MRI) for coverage details.

COVERED INDICATIONS

I. HEAD AND NECK

Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.A.2 and 220.2.B.2 for coverage details and guidelines on the use of MRA of the head and neck.

MRA is appropriately used to verify the presence of a condition, suspected because of findings from another test (usually an imaging study). For example, a patient who presents with a transient ischemic attack (TIA) should not undergo MRA simply because he might have a lesion which is amenable to surgery. However, if that patient has a carotid bruit and is found by Doppler study to have carotid stenosis, an MRA may be appropriate to evaluate the stenotic section of artery for surgical intervention. Please note that the anticipated surgery may be a percutaneous procedure such as carotid angioplasty with stent insertion.

Another patient may present with a headache; it is not appropriate to proceed directly to MRA to rule out the possibility of an intracranial aneurysm. However, if that patient was found to have a clinically significant amount of blood in the cerebrospinal fluid, or the patient demonstrated signs and symptoms strongly suggesting an unruptured intracranial aneurysm, an MRA (or cerebral angiogram) may be appropriate.

An MRA is not considered medically reasonable and necessary for screening asymptomatic patients for intracranial aneurysms.

II. PERIPHERAL ARTERIES OF LOWER EXTREMITIES

Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.b for coverage details and guidelines on the use of MRA in the peripheral arteries of the lower extremities.

III. ABDOMEN AND PELVIS

Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.c for coverage details and guidelines on the use of MRA in the pre-operative evaluation of patients undergoing elective abdominal aortic aneurysm (AAA) repair and imaging of the renal arteries and aortoiliac arteries in the absence of AAA or aortic dissection.

An MRA of the abdomen for evaluation of possible renal artery stenosis would not be considered medically reasonable and necessary without some evidence consistent with renovascular hypertension. Such evidence might include:

• a history of early or late onset of hypertension, hypertension refractory to medication, or worsening renal function;

• the presence of a renal artery bruit;

• laboratory tests (elevated serum renins, increasing creatinine); or

• other radiologic tests (ultrasound, captopril scintigraphy, or other imaging showing small kidney or unequal kidney sizes).

IV. CHEST

Diagnosis of Pulmonary Embolism

Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.d.i for coverage details and guidelines on the use of MRA in the diagnosis of pulmonary embolism.

Evaluation of Thoracic Aortic Dissection and Aneurysm

Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.d.ii for coverage details and guidelines on the evaluation of thoracic aortic dissection and aneurysm.

NOTE: This LCD does not address cardiac magnetic resonance imaging.

Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.

Summary of evidence (opening)

N/A

The contractor cites 2 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2020-07-01
Last reviewed by the contractor
2018-05-07
MCD version
72
Derived from
L31399

The contractor lists one National Coverage Determination as related: NCD 220.2 Magnetic Resonance Imaging. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Novitas Solutions, Inc. hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34865 cover?

Magnetic resonance angiography (MRA) is a non-invasive diagnostic test that is an application of magnetic resonance imaging (MRI). By analyzing the amount of energy released from tissues exposed to a strong magnetic field, MRA provides images of normal and diseased blood vessels as well as visualization and quantification of blood flow through these vessels. The full 684-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34865 apply to?

Novitas Solutions, Inc. applies it to Medicare claims in 11 states plus DC: AR, CO, DC, DE, LA, MD, MS, NJ, NM, OK, PA, TX. It binds only that contractor; 3 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34865?

The companion billing and coding article A56805 lists 999 ICD-10-CM codes in 4 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34865?

A denial under LCD L34865 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56805's 999 covered diagnosis codes, then file a redetermination with Novitas Solutions, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.